Gallagher H, Kwan J, Jayne RW: Pulmonary renal syndrome: a 4-year, single center experience. Am J Kidney Dis 2002, 38: 42-47.
Google Scholar
Goodpasture EW: The significance of certain pulmonary lesions in relation to the aetiology of pneumonia. Am J Med Sci 1919, 158: 863-870. 10.1097/00000441-191911000-00012
Google Scholar
Stanton MC, Tange JD: Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australas Ann Med 1958, 7: 132-144.
CAS
PubMed
Google Scholar
Lerner RA, Glassock KJ, Dixon FJ: The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967, 126: 989-1004. 10.1084/jem.126.6.989
PubMed Central
CAS
PubMed
Google Scholar
Specks U: Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001, 13: 12-17. 10.1097/00002281-200101000-00003
CAS
PubMed
Google Scholar
Collard HR, Schwarz MI: Diffuse alveolar hemorrhage. Clin Chest Med 2004, 25: 583-592. 10.1016/j.ccm.2004.04.007
PubMed
Google Scholar
Wiik A: Autoantibodies in vasculitis. Arthritis Res Ther 2003, 5: 147-152. 10.1186/ar758
PubMed Central
CAS
PubMed
Google Scholar
Langford C, Balow JE: New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney. Curr Opin Nephrol Hypertens 2003, 12: 267-272. 10.1097/00041552-200305000-00007
CAS
PubMed
Google Scholar
Brown KK: Pulmonary vasculitis. Proc Am Thorac Soc 2006, 3: 48-57. 10.1513/pats.200511-120JH
PubMed Central
CAS
PubMed
Google Scholar
Rodriguez W, Hanania N, Guy E, Guntupalli J: Pulmonary–renal syndromes in the intensive care unit. Crit Care Clin 2002, 18: 881-895. 10.1016/S0749-0704(02)00029-5
PubMed
Google Scholar
Merkel PA, Choi H, Niles JL: Evaluation and treatment of vasculitis in the critically ill patient. Crit Care Clin 2002, 18: 321-344. 10.1016/S0749-0704(01)00006-9
PubMed
Google Scholar
Camargo JF, Tobon GJ, Fonseca N, Diaz JL, Uribe M, Molina F, Anaya J-M: Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005, 14: 315-320. 10.1191/0961203305lu2082oa
CAS
PubMed
Google Scholar
Semple D, Keogh J, Forni L, Venn R: Clinical review: vasculitis on the intensive care unit-part 1: diagnosis. Crit Care 2005, 9: 92-97. 10.1186/cc2936
PubMed Central
PubMed
Google Scholar
Griffith M, Brett S: The pulmonary physician in critical care illustrative case 3: pulmonary vasculitis. Thorax 2003, 58: 543-546. 10.1136/thorax.58.6.543
PubMed Central
CAS
PubMed
Google Scholar
Davies DJ: Small vessel vasculitis. Cardiovasc Pathol 2005, 14: 335-346. 10.1016/j.carpath.2005.08.001
PubMed
Google Scholar
Erlich JH, Sevastos J, Pussell B: Goodpasture's disease: antiglomerular basement membrane disease. Nephrology 2004, 9: 49-51. 10.1111/j.1440-1797.2004.00244.x
PubMed
Google Scholar
Lau K, Wyatt R: Glomerulonephritis. Adolesc Med 2005, 16: 67-85. 10.1016/j.admecli.2004.09.008
Google Scholar
Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth : Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004, 350: 971-980. 10.1056/NEJMoa031855
CAS
PubMed
Google Scholar
Salama AD, Levy J, Lightstone L, Pusey CD: Goodpasture's disease. Lancet 2001, 358: 917-920. 10.1016/S0140-6736(01)06077-9
CAS
PubMed
Google Scholar
Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003, 348: 2543-2556. 10.1056/NEJMra022296
CAS
PubMed
Google Scholar
Bombassei GJ, Kaplan AA: The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Ind Med 1992, 21: 141-153. 10.1002/ajim.4700210204
CAS
PubMed
Google Scholar
Phelps RG, Jones V, Turner AN, Rees AJ: Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 2000, 12: 1135-1143. 10.1093/intimm/12.8.1135
CAS
PubMed
Google Scholar
Lou YH: Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease. Arch Immunol Ther Exp 2004, 52: 96-103.
CAS
Google Scholar
Sheerin NS, Springall T, Carroll MC, Sacks SH: Protection against antiglomerular basement membrane (GBM)-mediated nephritis in C3 and C4 deficient mice. Clin Exp Immunol 1997, 110: 403-409. 10.1046/j.1365-2249.1997.4261438.x
PubMed Central
CAS
PubMed
Google Scholar
Meyers KE, Allen J, Gehret J, Jacobovits A, Gallo M, Neilson EG, Hopfer H, Kalluri R, Madaio MP: Human antiglomerular basement membrane autoantibody disease in Xenomouse II. Kidney Int 2002, 61: 1666-1673. 10.1046/j.1523-1755.2002.00312.x
CAS
PubMed
Google Scholar
Csernok E: Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003, 2: 158-164. 10.1016/S1568-9972(03)00010-7
CAS
PubMed
Google Scholar
Frankel S, Cosgrove G, Fischer A, Meehan RT, Brown KK: Update in the diagnosis and management of pulmonary vasculitis. Chest 2006, 129: 452-465. 10.1378/chest.129.2.452
PubMed
Google Scholar
Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005, 352: 330-332. 10.1056/NEJMp048338
CAS
PubMed
Google Scholar
Langford C, Hoffman G: Wegener's granulomatosis. Thorax 1999, 54: 629-637.
PubMed Central
CAS
PubMed
Google Scholar
Savige J, Davies D, Falk R, Jennette JC, Wiik A: Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000, 57: 846-862. 10.1046/j.1523-1755.2000.057003846.x
CAS
PubMed
Google Scholar
Schwarz M, Brown K: Small vessel vasculitis of the lung. Thorax 2000, 55: 502-510. 10.1136/thorax.55.6.502
PubMed Central
CAS
PubMed
Google Scholar
Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P: Churg Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999, 78: 26-37. 10.1097/00005792-199901000-00003
CAS
PubMed
Google Scholar
Davies DJ, Moran JE, Niall JF, Ryan GB: Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? [Short report]. BMJ 1982, 285: 606.
PubMed Central
CAS
PubMed
Google Scholar
van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van ES LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 23: 425-429. 10.1016/S0140-6736(85)91147-X
Google Scholar
Bosch X, Guilabert A, Font J: Antineutrophil cytoplasmic antibodies. Lancet 2006, 368: 404-418. 10.1016/S0140-6736(06)69114-9
CAS
PubMed
Google Scholar
Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988, 318: 1651-1657.
CAS
PubMed
Google Scholar
Niles JL, McCluskey RT, Ahmad MF, Arnaout MA: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989, 74: 1888-1893.
CAS
PubMed
Google Scholar
Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110: 955-963. 10.1172/JCI200215918
PubMed Central
CAS
PubMed
Google Scholar
Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ: Pulmonary–renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45: 758-761. 10.1053/j.ajkd.2005.01.001
PubMed
Google Scholar
Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2006, 17: 1235-1242. 10.1681/ASN.2005101048
PubMed
Google Scholar
Pfister H, Ollert M, Frolich LF, Quintanilla-Martinez L, Colby TV, Specks U, Jenne DE: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004, 104: 1411-1418. 10.1182/blood-2004-01-0267
CAS
PubMed
Google Scholar
Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte microvascular interactions in vivo. Blood 2005, 106: 2050-2058. 10.1182/blood-2005-03-0921
CAS
PubMed
Google Scholar
Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk PJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167: 39-45.
PubMed Central
CAS
PubMed
Google Scholar
Seo P, Stone J: The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004, 117: 39-50. 10.1016/j.amjmed.2004.02.030
CAS
PubMed
Google Scholar
Booth A, Pusey C, Jayne D: Renal vasculitis – an update in 2004. Nephrol Dial Transplant 2004, 19: 1964-1968. 10.1093/ndt/gfh318
PubMed
Google Scholar
Niles JL, Böttinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT: The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996, 156: 440-445. 10.1001/archinte.156.4.440
CAS
PubMed
Google Scholar
Green R, Ruoss S, Kraft S, Dunkan SR, Berry GJ, Raffin TA: Pulmonary capillaritis and alveolar hemorrhage. Chest 1996, 110: 1305-1316.
CAS
PubMed
Google Scholar
Choi HK, Merkel PA, Walker AM, Niles JL: Drug associated anti-neutrophil cytoplasmic antibody positive vasculitis. Arthritis Rheum 2000, 43: 405-413. 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5
CAS
PubMed
Google Scholar
Schwarz MI, Fontenot AP: Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 2004, 25: 133-140. 10.1016/S0272-5231(03)00139-4
PubMed
Google Scholar
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M: Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005, 7: R1072-R1081. 10.1186/ar1789
PubMed Central
CAS
PubMed
Google Scholar
Jayne DR, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 1990, 37: 965-970.
CAS
PubMed
Google Scholar
Bosch X, Mirapeix E, Font J, Lopez-Soto A, Rodriguez R, Vivancos J, Revert L, Ingelmo M, Urbano-Marquez A: Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in antiglomerular basement disease. Clin Nephrol 1991, 36: 107-113.
CAS
PubMed
Google Scholar
Serratrice J, Chiche L, Dussol B, Granel B, Daniel L, Jego-Desplat S, Disdier P, Swiader L, Berland Y, Weiller PJ: Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004, 43: e26-e30. 10.1053/j.ajkd.2003.11.019
PubMed
Google Scholar
Hughson M, Zhi H, Henegar J, McMurray R: Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 2001, 125: 475-483.
CAS
PubMed
Google Scholar
Keane M, Lynch J: Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000, 55: 159-166. 10.1136/thorax.55.2.159
PubMed Central
CAS
PubMed
Google Scholar
Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H: Pulmonary renal syndrome in systemic sclerosis. Semin Arthritis Rheum 2001, 30: 403-410. 10.1053/sarh.2001.21904
CAS
PubMed
Google Scholar
Wutzl A, Foley R, O'Driscoll B, Reeve RS, Chisholm R, Herrick AL: Microscopic polyangiitis presenting as pulmonary renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Care Res 2001, 45: 533-536. 10.1002/1529-0131(200112)45:6<533::AID-ART379>3.0.CO;2-D
CAS
Google Scholar
Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002, 346: 752-763. 10.1056/NEJMra002974
CAS
PubMed
Google Scholar
Hanly JG: Antiphospholipid syndrome: an overview. CMAJ 2003, 168: 1675-1682.
PubMed Central
PubMed
Google Scholar
Gezer S: Antiphospholipid syndrome. Dis Mon 2003, 49: 696-741. 10.1016/S0011-5029(03)00184-6
PubMed
Google Scholar
Deane KD, West SG: Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005, 35: 154-165. 10.1016/j.semarthrit.2005.05.006
PubMed
Google Scholar
Panoskaltsis N, Derman MP, Perillo I, Brennan JK: Thrombotic thrombocytopenic purpura in Pulmonary–renal syndromes. Am J Hematol 2000, 65: 50-55. 10.1002/1096-8652(200009)65:1<50::AID-AJH9>3.0.CO;2-5
CAS
PubMed
Google Scholar
George JN: Thrombotic thrombocytopenic purpura. N Engl J Med 2006, 354: 1927-1935. 10.1056/NEJMcp053024
CAS
PubMed
Google Scholar
Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee B, Yang AY, Siemieniak DR, Stark KR, Gruppo R, et al.: Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001, 413: 488-494. 10.1038/35097008
CAS
PubMed
Google Scholar
Soejima K, Nakagaki T: Interplay between ADAMTS 13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies. Semin Hematol 2005, 42: 56-62. 10.1053/j.seminhematol.2004.09.008
CAS
PubMed
Google Scholar
Tsai HM, Rice L, Sarode R, Chow TW, Moake JL: Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Ann Intern Med 2000, 132: 794-799.
PubMed Central
CAS
PubMed
Google Scholar
Fontana S, Kremer Hovinga JA, Lammle B, Mansouri Taleghani B: Treatment of thrombotic thrombocytopenic purpura. Vox Sang 2006, 90: 245-254. 10.1111/j.1423-0410.2006.00747.x
CAS
PubMed
Google Scholar
Pourrat O, Bureau JM, Hira M, Martin-Barbaz F, Descamps JM, Robert R: Pronostic des maladies systémiques admises en réanimation: étude rétrospective de 39 séjours. Rev Méd Intern 2000, 21: 147-151. 10.1016/S0248-8663(00)88243-0
CAS
Google Scholar
Cruz BA, Ramanoelina J, Mahr A, Cohen P, Mouthon L, Cohen Y, Hoang P, Guillevin L: Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 2003, 42: 1183-1188. 10.1093/rheumatology/keg322
CAS
PubMed
Google Scholar
Gallagher H, Kwan JT, Jayne DR: Pulmonary–renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002, 39: 42-47.
PubMed
Google Scholar
Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramos-Casals M, Ingelmo M, Catastrophic Antiphospholipid Syndrome Registry Project Group: The acute respiratoty distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006, 65: 81-86. 10.1136/ard.2005.037671
PubMed Central
CAS
PubMed
Google Scholar
Manganelli P, Fietta P, Carotti M, Pesci A, Salaffi F: Respiratory system involvement in systemic vasculitides. Clin Exp Rheumatol 2006, 24: S48-S59.
CAS
PubMed
Google Scholar
Bouachour G, Roy PM, Tirot P, Quérin O, Gouello JR, Alquier P: Prognosis of systemic diseases diagnosed in intensive care units [in French]. Presse Méd 1996, 25: 837-841.
CAS
PubMed
Google Scholar
Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, de la Red G, Gil V, Ramos-Casals M, Garcia-Carrasco M, Ingelmo M, Font J: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004, 63: 1312-1317. 10.1136/ard.2003.014175
PubMed Central
CAS
PubMed
Google Scholar
Bowley NB, Steiner RE, Chin WS: The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Clin Radiol 1979, 30: 419-429. 10.1016/S0009-9260(79)80223-8
CAS
PubMed
Google Scholar
Papiris SA, Manoussakis MN, Drosos A, Kontogiannis D, Constantopoulos SH, Moutsopoulos HM: Imaging of thoracic Wegener's granulomatosis: the computed tomographic appearance. Am J Med 1992, 93: 529-536. 10.1016/0002-9343(92)90581-U
CAS
PubMed
Google Scholar
Ando Y, Okada F, Matsumoto S, Mori H: Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related disease. J Comput Assist Tomogr 2004, 28: 710-716. 10.1097/01.rct.0000135280.79012.c7
PubMed
Google Scholar
Jennings C, King T, Tuder R, Cherniack RM, Schwarz MI: Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med 1997, 155: 1101-1109.
CAS
PubMed
Google Scholar
Jennette JC, Wilkman AS, Falk RJ: Diagnostic predictive value of ANCA serology [editorial]. Kidney Int 1998, 53: 796-798.
CAS
PubMed
Google Scholar
Sinico RA, Radice A, Corace C, Sabadini E, Bollini B: Antiglomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 2006, 21: 397-401. 10.1093/ndt/gfi230
CAS
PubMed
Google Scholar
Salama A, Dougan T, Levy J, Cook HT, Morgan SH, Naudeer S, Maidment G, George AJ, Evans D, Lightstone L, Pussey CD: Goodpasture's disease in the absence of circulating anti-glomerular membrane antibodies as detected by standard techniques. Am J Kidney Dis 2002, 39: 1162-1167. 10.1053/ajkd.2002.33385
PubMed
Google Scholar
Hellmann M, Gerhardt T, Rabe C, Haas S, Sauerbruch T, Woitas RP: Goodpasture's syndrome with massive pulmonary haemorrhage in the absence of circulating anti-GBM antibodies? Nephrol Dial Transplant 2006, 21: 526-529. 10.1093/ndt/gfi279
PubMed
Google Scholar
Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS: Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 1991, 15: 315-333.
CAS
PubMed
Google Scholar
Frankel SK, Sullivan EJ, Brown KK: Vasculitis: Wegener granulomatosis, Churg–Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis. Crit Care Clin 2002, 18: 855-879. 10.1016/S0749-0704(02)00031-3
PubMed
Google Scholar
Sano K, Sakaguchi N, Ito M, Koyama M, Kobayashi M, Hotchi M: Histological diversity of vasculitic lesions in MPO-ANCA positive autopsy cases. Pathol Intern 2001, 51: 460-466. 10.1046/j.1440-1827.2001.01225.x
CAS
Google Scholar
Katzenstein AL: Diagnostic features and differential diagnosis of Churg–Strauss syndrome in the lung. A review. Am J Clin Pathol 2000, 114: 767-772. 10.1309/F3FW-J8EB-X913-G1RJ
CAS
PubMed
Google Scholar
Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pucey C, Pollack W, Trevisin M, et al.: Addentum to the International Consencus Statement on testing and reporting antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003, 120: 312-318. 10.1309/WAEP-ADW0-K4LP-UHFN
CAS
PubMed
Google Scholar
Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, et al.: Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome. Ann Intern Med 2005, 143: 632-638.
PubMed
Google Scholar
Falk RJ, Jennette JC: Thoughts about the classification of small vessel vasculitis. J Nephrol 2004,17(Suppl 8):S3-S9.
PubMed
Google Scholar
Vassilopoulos D, Hoffman G: Clinical utility of testing for anti-neutrophil cytoplasmic antibodies. Clin Diagn Lab Immunol 1999, 6: 645-651.
PubMed Central
CAS
PubMed
Google Scholar
Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 1994, 24: 130-141.
CAS
PubMed
Google Scholar
Agard C, Mouthon L, Mahr A, Guillevin L: Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum 2003, 49: 709-715. 10.1002/art.11387
PubMed
Google Scholar
Niles JA: A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis, the contra view. Sarcoidosis Vasc Diffuse Lung Dis 1996, 13: 232-234.
CAS
PubMed
Google Scholar
Tesar V, Rihova Z, Jancova E, Rysova R, Merta M: European randomized trials: current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials. Nephrol Dial Transplant 2003, 18: v2-v4. 10.1093/ndt/gfg1032
PubMed
Google Scholar
Hogan S, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small vessel vasculitis. Ann Intern Med 2005, 143: 621-631.
PubMed
Google Scholar
Rihova Z, Jancova E, Merta M, Tesar V: Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis – preliminary single center experience. Prague Med Rep 2004, 105: 64-68.
CAS
PubMed
Google Scholar
Gaskin G, Pusey C: Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Ther Apher 2001, 5: 176-181. 10.1046/j.1526-0968.2001.00300.x
CAS
PubMed
Google Scholar
Klemmer P, Chalermskulrat W, Reif M, Hogan SL, Henke DC, Falk RJ: Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003, 42: 1149-1153. 10.1053/j.ajkd.2003.08.015
PubMed
Google Scholar
Ahmed SH, Aziz T, Cochran J, Highland K: Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest 2004, 126: 305-309. 10.1378/chest.126.1.305
PubMed
Google Scholar
Henke DC, Falk RJ, Gabriel DA: Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med 2004, 140: 493-494.
PubMed
Google Scholar
Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, et al.: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349: 36-44. 10.1056/NEJMoa020286
CAS
PubMed
Google Scholar
White ES, Lynch JP: Pharmacological therapy for Wegener's granulomatosis. Drugs 2006, 66: 1209-1228. 10.2165/00003495-200666090-00004
CAS
PubMed
Google Scholar
Booth A, Harper L, Hammad T, Bacon P, Griffith M, Levy J, Savage C, Pusey C, Jayne D: Prospective study of TNF alpha blockade with infliximab in antineutrophil cytoplasmic antibody-assocaited systemic vasculitis. J Am Soc Nephrol 2004, 15: 717-721. 10.1097/01.ASN.0000114554.67106.28
CAS
PubMed
Google Scholar
Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL, Gause A: Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. Rheumatology (Oxford) 2002, 41: 1303-1307. 10.1093/rheumatology/41.11.1303
CAS
Google Scholar
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group: Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005, 352: 351-361. 10.1056/NEJMoa041884
Google Scholar
Feldman M, Pusey CD: Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons fron other chronic inflammatory diseases. J Am Soc Nephrol 2006, 17: 1243-1252. 10.1681/ASN.2005121359
Google Scholar
Stasi R, Stipa E, del Poeta GD, Amadori S, Newland AC, Provan D: Long term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 2006, 45: 1432-1436. 10.1093/rheumatology/kel098
CAS
Google Scholar
Antoniu SA: Rituximab for refractory Wegener's granulomatosis. Exp Opin Invest Drugs 2006, 15: 1115-1117. 10.1517/13543784.15.9.1115
CAS
Google Scholar
Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999, 10: 1965-1971.
CAS
PubMed
Google Scholar
Langford CA, Talar-Williams C, Sneller MC: Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004, 51: 278-283. 10.1002/art.20240
CAS
PubMed
Google Scholar
Koukoulaki M, Jayne DR: Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 2006, 102: c100-c107. 10.1159/000089667
CAS
PubMed
Google Scholar
Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E: Maintenance of remission with leflunomide in Wegener's granulomatosis. Rheumatology (Oxford) 2004, 43: 315-320. 10.1093/rheumatology/keh009
CAS
Google Scholar
Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ, European Vasculitis Study Group: Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65: 1440-1448. 10.1111/j.1523-1755.2004.00534.x
CAS
PubMed
Google Scholar
Levy JB, Turner AN, Rees AJ, Pusey CD: Long term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134: 1033-1042.
CAS
PubMed
Google Scholar
Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986, 314: 614-619.
PubMed
Google Scholar
Ginzler E, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, et al.: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005, 353: 2219-2228. 10.1056/NEJMoa043731
CAS
PubMed
Google Scholar
Smith KG, Jones RB, Burns SM, Jayne DR: Long term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 2006, 54: 2970-2982. 10.1002/art.22046
CAS
PubMed
Google Scholar
Candan S, Pirat A, Varol A, Torgay A, Zeyneloglou P, Arslan G: Respiratory problems in renal transplant recipients admitted to intensive care during long-term follow-up. Transplant Proc 2006, 38: 1354-1356. 10.1016/j.transproceed.2006.02.083
CAS
PubMed
Google Scholar